These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37087436)

  • 1. Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic.
    Zhu W; Wen Z; Chen Y; Gong X; Zheng B; Liang X; Xu A; Yao Y; Wang W
    BMC Public Health; 2023 Apr; 23(1):743. PubMed ID: 37087436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
    Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jul; ():. PubMed ID: 35898339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    Lancet Reg Health West Pac; 2022 Dec; 29():100592. PubMed ID: 36090701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy choices for Shanghai responding to challenges of Omicron.
    Qian Y; Cao S; Zhao L; Yan Y; Huang J
    Front Public Health; 2022; 10():927387. PubMed ID: 36016887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.
    Xin H; Wang Z; Feng S; Sun Z; Yu L; Cowling BJ; Kong Q; Wu P
    Int J Infect Dis; 2023 Jan; 126():132-135. PubMed ID: 36511336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study.
    Wei Z; Ma W; Wang Z; Li J; Fu X; Chang H; Qiu Y; Tian H; Zhu Y; Xia A; Wu Q; Liu G; Zhai X; Zhang X; Wang Y; Zeng M
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13097. PubMed ID: 36843225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission Characteristics and Predictive Model for Recent Epidemic Waves of COVID-19 Associated With OMICRON Variant in Major Cities in China.
    Zheng Y; Wang Y
    Int J Public Health; 2022; 67():1605177. PubMed ID: 36405530
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of close contact settings with transmission and infection during the SARS-CoV-2 Omicron BA.2 epidemic in Shanghai.
    Zhu W; Yuan S; Mao S; Chen J; Zheng Y; Jiang X; Yu X; Jiang C; Fang Q; Wang W; Yuan Z; Yao Y
    BMJ Glob Health; 2023 Dec; 8(12):. PubMed ID: 38135296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
    Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):2800-2807. PubMed ID: 36205530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level.
    Zheng JX; Lv S; Tian LG; Guo ZY; Zheng PY; Chen YL; Guan SY; Wang WM; Zhang SX
    Infect Dis Poverty; 2022 Nov; 11(1):114. PubMed ID: 36434701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case clustering, contact stratification, and transmission heterogeneity of SARS-CoV-2 Omicron BA.5 variants in Urumqi, China: An observational study.
    Lu Y; Guo Z; Zeng T; Sun S; Lu Y; Teng Z; Tian M; Wang J; Li S; Fan X; Luan Z; Wang W; Cai Y; Wang K; Zhao S
    J Glob Health; 2023 May; 13():06018. PubMed ID: 37199483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of patients from fever clinics during the COVID-19 epidemic in 2022 in Shanghai, China.
    Zhang Y; Wang J; Xie Y; Cao X; Huang H; Liu Q; Hang X; Wang J
    Arch Virol; 2023 May; 168(6):164. PubMed ID: 37209311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China.
    Xiao J; Hu J; He G; Liu T; Kang M; Rong Z; Lin L; Zhong H; Huang Q; Deng A; Zeng W; Tan X; Zeng S; Zhu Z; Li J; Gong D; Wan D; Chen S; Guo L; Li Y; Li Y; Sun L; Liang W; Song T; He J; Ma W
    Int J Infect Dis; 2021 Feb; 103():617-623. PubMed ID: 33181330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological characteristics of two local COVID-19 outbreaks caused by 2019-nCoV Omicron variant in Guangzhou, China].
    Huang Y; Zheng ZW; Chen C; Li K; Chen SY; Chen YY; Jing QL; Ma Y; Luo L; Yang ZC; Zhang ZB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1705-1710. PubMed ID: 36444451
    [No Abstract]   [Full Text] [Related]  

  • 17. How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share.
    Cai W; Yang Z; Liang J; Lin Z; Ma Y; Chen C; Li Y; Li Y; Mai Z; Mai K; Kong X; Liang X; Li Q; Tu C; Chen C; Hon C; Qin P; Li K; Li X; Miao Y; Liu X; Guan W; Zeng Z; Qiu W; He W; Zhang L; Yang Z; Zhong N
    Front Public Health; 2022; 10():979063. PubMed ID: 36620243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of control measures during the 2022 COVID-19 outbreak in Shanghai, China.
    Hu L; Shi M; Li M; Ma J
    PLoS One; 2023; 18(5):e0285937. PubMed ID: 37200400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric analysis of the transmission dynamics during indigenous aggregated outbreaks caused by five SARS-CoV-2 strains in Nanjing, China.
    Ma T; Chen C; Wang J; Wang H; Zhao Y; Zhu Y; Yan Z; Ding S; Ding J
    Front Public Health; 2024; 12():1358577. PubMed ID: 38525336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.